Cargando…

Type 2 Diabetes Mellitus and Macrovascular Complications

Detalles Bibliográficos
Autores principales:	Shan, Peng-Fei, Li, Qian, Khamaisi, Mogher, Qiang, Gui-fen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694615/ https://www.ncbi.nlm.nih.gov/pubmed/29230243 http://dx.doi.org/10.1155/2017/4301461

Ejemplares similares

Micro- and Macrovascular Complications in Diabetes Mellitus: Preclinical and Clinical Studies
por: Rangel, Érika B., et al.
Publicado: (2019)

Stem Cells for Diabetes Complications: A Future Potential Cure
por: Khamaisi, Mogher, et al.
Publicado: (2017)

Genetics of macrovascular complications in type 2 diabetes
por: Tonyan, Ziravard N, et al.
Publicado: (2021)

Serum vaspin concentration in elderly patients with type 2 diabetes mellitus and macrovascular complications
por: Yang, Wei, et al.
Publicado: (2017)

Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?
por: Chawla, Aastha, et al.
Publicado: (2016)

Cost of diabetes mellitus and related macrovascular complications in Turkiye
por: Birinci, Suayip, et al.
Publicado: (2023)

Microvascular and macrovascular complications of type 2 diabetic mellitus in Central, Kingdom of Saudi Arabia
por: Alaboud, Aboud F., et al.
Publicado: (2016)

SUBCLINICAL HYPOTHYROIDISM AS A CONTRIBUTOR TO MACROVASCULAR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
por: Marushchak, Mariya, et al.
Publicado: (2021)

Microvascular and macrovascular complications of type 2 diabetes mellitus: Exome wide association analyses
por: Mansour, Afnan, et al.
Publicado: (2023)

Macrovascular complication phenotypes in type 2 diabetic patients
por: Papa, Giuseppe, et al.
Publicado: (2013)

Comments on: Microvascular and macrovascular complications in diabetes mellitus: Distinct or continuum?
por: Chauhan, Anubhav, et al.
Publicado: (2016)

Why Is Diabetes Mellitus a Risk Factor for Contrast-Induced Nephropathy?
por: Heyman, Samuel N., et al.
Publicado: (2013)

Levels of soluble cell adhesion molecules in type 2 diabetes mellitus patients with macrovascular complications
por: Hegazy, Gehan A, et al.
Publicado: (2019)

Role of the JAK2/STAT3 signaling pathway in the pathogenesis of type 2 diabetes mellitus with macrovascular complications
por: Yang, Mengxue, et al.
Publicado: (2017)

Epidemiology of Micro- and Macrovascular Complications of Type 2 Diabetes in Korea
por: Kim, Jung Hee, et al.
Publicado: (2011)

Macrovascular Complications and Prevalence of Urgency Incontinence in Japanese Patients with Type 2 Diabetes Mellitus: The Dogo Study
por: Furukawa, Shinya, et al.
Publicado: (2017)

Serum electrolyte levels in relation to macrovascular complications in Chinese patients with diabetes mellitus
por: Wang, Shenqi, et al.
Publicado: (2013)

Prevention of macrovascular complications in patients with type 2 diabetes mellitus: Review of cardiovascular safety and efficacy of newer diabetes medications
por: Kant, Ravi, et al.
Publicado: (2019)

Association between mean platelet volume in the pathogenesis of type 2 diabetes mellitus and diabetic macrovascular complications in Japanese patients
por: Inoue, Hiroyuki, et al.
Publicado: (2020)

Macrovascular Complications in Patients with Diabetes and Prediabetes
por: Huang, Dou, et al.
Publicado: (2017)

Protective role of NRF2 in macrovascular complications of diabetes
por: Wu, Junduo, et al.
Publicado: (2020)

NLRP3 Inflammasome Polymorphism and Macrovascular Complications in Type 2 Diabetes Patients
por: Klen, Jasna, et al.
Publicado: (2015)

Plasma total homocysteine and macrovascular complications are associated with food and nutrient intake in patients with Type II diabetes mellitus
por: Chang, Namsoo, et al.
Publicado: (2007)

Early aggressive macrovascular disease and type 1 diabetes mellitus without chronic complications: a case report
por: Saldanha de Mattos Matheus, Alessandra, et al.
Publicado: (2013)

Osteopontin for Early Detection of Microvascular and Macrovascular Type 1 Diabetic Complication
por: El Dayem, Soha M. Abd, et al.
Publicado: (2019)

Treatment of specific macrovascular beds in patients with diabetes mellitus
por: Petznick, Allison M, et al.
Publicado: (2010)

Association of Combined TCF7L2 and KCNQ1 Gene Polymorphisms with Diabetic Micro- and Macrovascular Complications in Type 2 Diabetes Mellitus
por: Rattanatham, Rujikorn, et al.
Publicado: (2021)

Correlation Analysis between Serum Vitamin D Levels and Lower Extremity Macrovascular Complications in Individuals with Type 2 Diabetes Mellitus
por: Yang, Mengxue, et al.
Publicado: (2019)

Early detection of macrovascular complications in type 2 diabetes mellitus in Medan, North Sumatera, Indonesia: A cross-sectional study
por: Amelia, Rina, et al.
Publicado: (2021)

Association of triglyceride glucose index and triglyceride HDL ratio with glucose levels, microvascular and macrovascular complications in Diabetes Mellitus Type-2
por: Jabeen, Wajiha Mah, et al.
Publicado: (2023)

Associations of Thyroid Hormone Levels and Macrovascular Complications in Euthyroid Type 2 Diabetic Patients
por: Hu, Yonghui, et al.
Publicado: (2021)

Combined evaluation of arterial stiffness, glycemic control and hypertension for macrovascular complications in type 2 diabetes
por: Wu, Zhiyuan, et al.
Publicado: (2022)

Cardiovascular Complications of Diabetes: From Microvascular to Macrovascular Pathways
por: Zakir, Mehreen, et al.
Publicado: (2023)

Glycated albumin and the risk of micro- and macrovascular complications in subjects with Type 1 Diabetes
por: Yoon, Hye-jin, et al.
Publicado: (2015)

Relation Between Different Measures of Glycemic Exposure and Microvascular and Macrovascular Complications in Patients with Type 2 Diabetes Mellitus: An Observational Cohort Study
por: van Wijngaarden, Rients P. T., et al.
Publicado: (2017)

Variant rs2237892 of KCNQ1 Is Potentially Associated with Hypertension and Macrovascular Complications in Type 2 Diabetes Mellitus in A Chinese Han Population
por: Zhang, Wanlin, et al.
Publicado: (2015)

Prevalence and incidence of microvascular and macrovascular complications over 15 years among patients with incident type 2 diabetes
por: An, Jaejin, et al.
Publicado: (2021)

Potential benefit of (-)-epigallocatechin-3-gallate for macrovascular complications in diabetes
por: Tang, L., et al.
Publicado: (2017)

Aortic Stiffness as a Surrogate Endpoint to Micro- and Macrovascular Complications in Patients with Type 2 Diabetes
por: Cardoso, Claudia R. L., et al.
Publicado: (2016)

The Effect of Dipeptidyl Peptidase-4 Inhibitors on Macrovascular and Microvascular Complications of Diabetes Mellitus: A Systematic Review
por: Taylor, Olesya M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sot76jhljfhrertmd1hdu54c4c